# Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients

> **NCT05221593** · PHASE3 · COMPLETED · sponsor: **Al-Azhar University** · enrollment: 50 (actual)

## Conditions studied

- Neutropenia

## Interventions

- **DRUG:** Lithium Carbonate

## Key facts

- **NCT ID:** NCT05221593
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05221593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05221593, "Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05221593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*